Harvey refuted the claims regarding Iclusig safety, gave updates on everything, and answered every question.
For me, you refute with actual data.
He provided no data.
It's also amateurish to let a small one man operation get to you. You have a drug that you think is selling ahead of analyst expectations, so the best thing to do is to keep quiet and let the numbers do the talking.
And this sets a very silly precedent: Is he going to have one of these 90 minute gab-fests every time some hack surveys a few oncologists? No. So why do it for this one?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.